Astiban therapy of urinary schistosomiasis: a quantitative evaluation
- 31 May 1966
- journal article
- research article
- Published by Taylor & Francis in Pathogens and Global Health
- Vol. 60 (2) , 165-168
- https://doi.org/10.1080/00034983.1966.11686401
Abstract
Seventeen Egyptian male patients infected with Schistosoma haematobium were treated with Astiban at a dosage of 8 mgn./kgn. body weight/dose given intramuscularly twice weekly for 5 injections. Bell''s egg-count technique was used to evaluate the therapeutic results quantitatively. Three months after treatment there was a 90% reduction in egg excretion, a therapeutic result that conforms closely to Bell''s results in the treatment of S. mansoni in East Africa.This publication has 4 references indexed in Scilit:
- Treatment of urinary schistosomiasis with Astiban and with Astiban acid in oil: a quantitative evaluationPathogens and Global Health, 1965
- Treatment of Urinary Schistosomiasis in Ghanaians with TWSb (Astiban®)The American Journal of Tropical Medicine and Hygiene, 1964
- TWSb inSchistosoma MansoniInfections: A Quantitative EvaluationPathogens and Global Health, 1964
- Ambulant treatment of urinary schistosomiasis with astiban (TWSb/6)Transactions of the Royal Society of Tropical Medicine and Hygiene, 1962